Mereo BioPharma Group PLC (MREO)

3.155 +0.10 (+3.10%) USD  |  NASDAQ  |  May 01, 16:00
3.155 0.00 (0.00%) After-Hours: 20:00
More

Mereo BioPharma Group Shareholders Equity (Quarterly): 50.54M for Dec. 31, 2023

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2015. Upgrade now.
Date Value
December 31, 2023 50.54M
June 30, 2023 72.83M
June 30, 2023 72.83M
December 31, 2022 51.40M
June 30, 2022 84.40M
June 30, 2022 84.40M
December 31, 2021 118.77M
June 30, 2021 111.66M
June 30, 2021 111.66M
December 31, 2020 -20.40M
June 30, 2020 29.84M
June 30, 2020 29.84M
December 31, 2019 52.78M
Date Value
June 30, 2019 74.81M
June 30, 2019 74.81M
December 31, 2018 41.58M
June 30, 2018 61.64M
June 30, 2018 61.64M
December 31, 2017 84.44M
June 30, 2017 96.32M
June 30, 2017 96.32M
December 31, 2016 97.79M
June 30, 2016 121.31M
June 30, 2016 121.31M
December 31, 2015 52.95M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

-20.40M
Minimum
Dec 2020
118.77M
Maximum
Dec 2021
66.68M
Average
72.83M
Median
Jun 2023

Shareholders Equity (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC 39.51M
Biodexa Pharmaceuticals Plc 5.959M
NuCana PLC 18.96M
TC BioPharm (Holdings) PLC 3.421M
Autolus Therapeutics PLC 111.47M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 66.50M
Total Liabilities (Quarterly) 15.96M
Debt to Equity Ratio 0.0869
Current Ratio 6.722
Net Debt Paydown Yield 1.54%